These data provided evidence for a critical and unique role of IL-1 in upregulating cytokines (e.g. IL-17) and in determining the balance between inflammation and antitumor immunity in specific tumor microenvironments such as in the lung (Carmi et al., 2011). The gene discussed is IL17A; the disease is neoplasm.